Taysha Gene Therapies
TSHA
#5151
Rank
โ‚น179.46 B
Marketcap
โ‚น624.51
Share price
3.47%
Change (1 day)
154.19%
Change (1 year)

Market capitalization of Taysha Gene Therapies (TSHA)

Market cap: โ‚น179.46 Billion

As of August 2026 Taysha Gene Therapies has a market cap of โ‚น179.46 Billion. This makes Taysha Gene Therapies the world's 5151th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Taysha Gene Therapies from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น179.46 B25.18%
2025โ‚น143.35 B365.94%
2024โ‚น30.76 B11.68%
2023โ‚น27.54 B135.91%
2022โ‚น11.67 B-65%
2021โ‚น33.36 B-54.48%
2020โ‚น73.29 B

End of Day market cap according to different sources

On Aug 6th, 2026 the market cap of Taysha Gene Therapies was reported to be:

โ‚น173.44 Billion
by Nasdaq info icon info icon
โ‚น173.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น133.21 B-25.77%๐Ÿ‡บ๐Ÿ‡ธ USA